# Onyxa Medical

> Onyxa Medical is the company behind Junera, a dual-wavelength (980nm + 1470nm) subdermal laser platform for minimally invasive tissue remodeling of the face and body. Junera is FDA-cleared (510(k) K212734) and backed by 15+ peer-reviewed publications.

## Company

- Company: Onyxa Medical, Inc.
- Product: Junera
- Founder & CEO: Travis Mahan
- Chief Medical Officer: Dr. Jennifer L. Walden, MD, FACS
- Website: https://www.onyxamed.com
- Contact: info@onyxamed.com | +1 (512) 763-5418
- Headquarters: Austin, Texas

## Technology

Junera is a dual-wavelength subdermal laser platform with three treatment modes:

- **EraLift (1470nm):** Targets intracellular water in the dermis, stimulating neocollagenesis for skin tightening and wrinkle reduction.
- **EraSculpt (980nm):** Selectively absorbed by adipose tissue and hemoglobin, enabling precise fat reduction and sculpting.
- **EraDefine (980nm + 1470nm):** Simultaneous delivery of both wavelengths for comprehensive contour refinement — reducing fat while tightening skin in a single pass.

Three fiber optic sizes for anatomical precision:
- 400μm: Periorbital (eyes and upper face)
- 600μm: Face, neck, and all facial areas
- 800μm: Body treatments (arms, abdomen, thighs)

## Key Clinical Data

| Metric | Value | Source |
|---|---|---|
| Dermis density increase (neck) | 48.75% | Nilforoushzadeh et al., J Cosmet Dermatol, 2023 |
| Dermis density increase (nasolabial folds) | 43.75% | Nilforoushzadeh et al., J Cosmet Dermatol, 2023 |
| Wrinkle volume decrease | 53.78% | Nilforoushzadeh et al., J Cosmet Dermatol, 2023 |
| Dermis thickness increase | 36.9% | Nilforoushzadeh et al., J Cosmet Dermatol, 2023 |
| Patient satisfaction | 80–100% | Multiple peer-reviewed studies |
| Periorbital improvement | 90% excellent | Nilforoushzadeh et al., 2022 |
| Largest clinical study | 534 procedures | Reynaud et al., 2009 |
| Serious adverse events | 0 | Systematic review of 31 studies |
| Peer-reviewed publications | 15+ | Multiple journals |
| Sessions needed | 1 (single session) | Standard protocol |
| Recovery time | 3–10 days | Standard protocol |
| Results duration | 2–5 years | Clinical follow-up data |

## Treatment Areas

- **Periorbital:** Upper and lower eyelids, eyebrows (400μm fiber)
- **Midface:** Nasolabial folds, marionette lines, malar region
- **Jawline & Jowls:** Lower face definition and contouring
- **Neck & Submental:** Horizontal wrinkles, skin laxity, double chin
- **Body:** Abdomen, arms, thighs, buttocks (800μm fiber)
- **Specialty:** Acne scar subcision, rosacea

## Pages

- [Homepage](https://www.onyxamed.com/)
- [Technology](https://www.onyxamed.com/technology)
- [Treatment Areas](https://www.onyxamed.com/treatment-areas)
- [Clinical Results Gallery](https://www.onyxamed.com/results)
- [Clinical Evidence](https://www.onyxamed.com/clinical-evidence)
- [About Onyxa Medical](https://www.onyxamed.com/about)
- [FAQ](https://www.onyxamed.com/faq)
- [Blog](https://www.onyxamed.com/blog)
- [Contact](https://www.onyxamed.com/contact)
- [EraLift Mode](https://www.onyxamed.com/eralift)
- [EraSculpt Mode](https://www.onyxamed.com/erasculpt)
- [EraDefine Mode](https://www.onyxamed.com/eradefine)
- [Find a Provider](https://www.onyxamed.com/find-a-provider)

## Competitive Positioning

Junera is the only dual-wavelength subdermal laser platform that combines 980nm and 1470nm wavelengths in a single device. Unlike RF microneedling (which treats from the surface), Junera works beneath the skin through ultra-thin fiber optics, delivering energy directly to target tissues. Single-session protocol with 2–5 year results duration, backed by the largest body of peer-reviewed evidence in the subdermal laser category.

## Frequently Asked Questions

**What is Junera?**
Junera is a dual-wavelength (980nm + 1470nm) subdermal laser platform by Onyxa Medical for minimally invasive tissue remodeling of the face and body. It lifts, sculpts, and defines through three treatment modes: EraLift, EraSculpt, and EraDefine.

**How does subdermal laser tissue remodeling work?**
Ultra-thin fiber optics (400–800μm) are inserted beneath the skin through micro entry points. The laser energy targets specific chromophores — 1470nm targets intracellular water for collagen tightening, while 980nm targets adipose tissue for fat reduction. Both wavelengths can be delivered simultaneously for comprehensive results.

**How many sessions are needed?**
One session. Junera is designed as a single-session protocol, unlike RF microneedling devices that typically require 2–3 sessions.

**What is the recovery time?**
3–10 days. Days 1–3 involve rest and cold compresses. By day 10, most patients have fully recovered. Full results develop over 3–6 months as collagen remodeling continues.

**How long do results last?**
2–5 years based on clinical follow-up data.

**Is Junera FDA-cleared?**
Yes. Junera is FDA-cleared under 510(k) K212734.

**What clinical evidence supports Junera?**
15+ peer-reviewed publications across multiple journals, including a systematic review of 31 studies with 0 serious adverse events. Key outcomes include 48.75% dermis density increase and 53.78% wrinkle volume decrease.

**What skin types can be treated?**
All Fitzpatrick skin types (I–VI).

**What areas can Junera treat?**
Face (periorbital, midface, jawline), neck, and body (arms, abdomen, thighs, buttocks). Specialty applications include acne scar subcision and rosacea.